Endovascular therapy in hyperacute ischaemic stroke: History and current status

Interventional Neuroradiology

Volumn 19, Issue 4, 2013, Pages 506-518

  Mortimer, Alex M ^a   Bradley, Marcus D ^a   Renowden, Shelley A ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Endovascular; Solitaire; Stent retriever; Stroke; Thrombectomy; Thrombolysis; Trevo

Indexed keywords

ALTEPLASE; PROUROKINASE;

BLEEDING; BLOOD CLOT LYSIS; BLOOD VESSEL OCCLUSION; BRAIN ISCHEMIA; CLINICAL TRIAL; DRUG EFFICACY; DRUG TREATMENT FAILURE; EMBOLECTOMY SYSTEM; ENDOVASCULAR SURGERY; ENDOVASCULAR THERAPY; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; LARGE VESSEL OCCLUSION; MECHANICAL THROMBECTOMY; META ANALYSIS (TOPIC); NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NONSURGICAL INVASIVE THERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; REVIEW; STENT RETRIEVER; SYSTEMATIC REVIEW (TOPIC); THROMBECTOMY; TIME TO TREATMENT; TREATMENT FAILURE;

EID: 84893177247     PISSN: 15910199     EISSN: None     Source Type: Journal    
DOI: 10.1177/159101991301900417     Document Type: Review

References (91)

1. Smith WS, Lev MH, English JD, et al. Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA. Stroke. 2009; 40: 3834-3840.
2. Nedeltchev K, Schwegler B, Haefeli T, et al. Outcome of stroke with mild or rapidly improving symptoms. Stroke. 2007; 38 (9): 2531-2535. (Pubitemid 47329633)
3. Fiehler J, Knudsen K, Thomalla G, et al. Vascular occlusion sites determine differences in lesion growth from early apparent diffusion coefficient lesion to final infarct. Am J Neuroradiol. 2005; 26 (5): 1056-1061. (Pubitemid 43821948)
4. Bamford J, Sandercock P, Dennis M, et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991; 337 (8756): 1521-1526.
5. Furlan A, Higashida R, Wechsler L, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA. 1999; 282 (21): 2003-2011.
6. Janardhan V, Carlson L, Gianatasio R, et al. Natural history of acute ischaemic stroke from large vessel occlusion demonstrates efficacy of mechanical thrombectomy: preliminary results of the penumbra FIRST study. J Neurointerv Surg. 2013; 5 (Suppl 2): A4-A5.
7. Gonzalez RG, Furie KL, Goldmacher GV, et al. Good outcome rate of 35% in IV-tPA-treated patients with computed tomography angiography confirmed severe anterior circulation occlusive stroke. Stroke. 2013. [Epub ahead of print]
8. Mokin M, Kass-Hout T, Kass-Hout O, et al. Intravenous thrombolysis and endovascular therapy for acute ischemic stroke with internal carotid artery occlusion: a systematic review of clinical outcomes. Stroke. 2012; 43 (9): 2362-2368.
9. Schulte-Altedorneburg G, Hamann GF, Mull M, et al. Outcome of acute vertebrobasilar occlusions treated with intra-arterial fibrinolysis in 180 patients. Am J Neuroradiol. 2006; 27 (10): 2042-2047. (Pubitemid 44788625)
10. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke. 2007; 38 (3): 967-973. (Pubitemid 46568460)
11. Mazighi M, Serfaty JM, Labreuche J, et al. Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol. 2009; 8 (9): 802-809.
12. Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013; 368 (10): 893-903.
13. Kwiatkowski TG, Libman RB, Frankel M, et al. Effects of tissue plasminogen activator for acute ischemic stroke at one year. N Engl J Med. 1999; 340 (23), 1781-1787. (Pubitemid 29266401)
14. Rai AT, Carpenter JS, Raghuram K, et al. Endovascular therapy yields significantly superior outcomes for large vessel occlusions compared with intravenous thrombolysis: is it time to randomize? J Neurointerv Surg. 2013; 5 (5): 430-434.
15. Mathews MS, Sharma J, Snyder KV, et al. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset. Neurosurgery. 2009; 65 (5): 860-865.
16. Fredieu A, Duckwiler GR, Starkman S, et al. Clot burden in acute ischemic stroke: relation to occlusion site and the success of revascularization therapy (abstract). Stroke. 2005; 36: 449.
17. Riedel CH, Zimmermann P, Jensen-Kondering U, et al. The importance of size: successful recanalization by intravenous thrombolysis in acute anterior stroke depends on thrombus length. Stroke. 2011; 42 (6): 1775-1777.
18. Manelfe C, Larrue V, von Kummer R, et al. Association of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke. 1999; 30 (4): 769-772. (Pubitemid 29156366)
19. Nichols C, Khoury J, Brott T, et al. Intravenous recombinant tissue plasminogen activator improves arterial recanalization rates and reduces infarct volumes in patients with hyperdense artery sign on baseline computed tomography. J Stroke Cerebrovasc Dis. 2008; 17 (2): 64-68. (Pubitemid 351381443)
20. Kharitonova T, Ahmed N, Thorén M, et al. Hyperdense middle cerebral artery sign on admission CT scanprognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register. Cerebrovasc Dis. 2009; 27 (1): 51-59.
21. NINDS rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995; 333 (24): 1581-1587.
22. Saqqur M, Uchino K, Demchuk AM, et al. Site of arterial occlusion identified by transcranial Doppler prediets the response to intravenous thrombolysis for stroke. Stroke. 2007; 38 (3), 948-954. (Pubitemid 46568457)
23. Bhatia R, Hill MD, Shobha N, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010; 41 (10): 2254-2258.
24. del Zoppo GJ, Poeck K, Pessin MS, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol. 1992; 32 (1): 78-86.
25. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology. 1992; 42 (5): 976-982.
26. Wolpert SM, Caplan LR. Current role of cerebral angiography in the diagnosis of cerebrovascular diseases. Am J Roentgenol. 1992; 159 (1): 191-197.
27. Ribo M, Delgado-Mederos R, Molina CA, et al. Temporal profile of recanalization after intravenous tissue plasminogen activator: Selecting patients for rescue reperfusion techniques. Stroke. 2006; 37 (4): 1000-1004.
28. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, et al. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA Acute Stroke Study Group. Am J Neuroradiol. 1993; 14 (1): 3-13. (Pubitemid 23055914)
29. Georgiadis D,Wirz F, von Budingen HC, et al. Intravenous thrombolysis in stroke patients with hyperdense middle cerebral artery sign. Eur J Neurol. 2009; 16 (2): 162-167.
30. Wunderlich MT, Goertler M, Postert T, et al. Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology. 2007; 68 (17): 1364-1368. (Pubitemid 46659087)
31. Murphy A, Symons SP, Hopyan J, et al. Factors influencing clinically meaningful recanalization after IV-rtPA in acute ischemic stroke. Am J Neuroradiol. 2013; 34 (1): 146-152.
32. Thomalla G, Kruetzelmann A, Siemonsen S, et al. Clinical and tissue response to intravenous thrombolysis in tandem internal carotid artery/middle cerebral artery occlusion: an MRI study. Stroke. 2008; 39 (5): 1616-1618.
33. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002; 59 (6): 862-867.
34. Flint AC, Duckwiler GR, Budzik RF, et al. MERCI and Multi MERCI Writing Committee mechanical thrombectomy of intracranial internal carotid occlusion: pooled results of the MERCI and Multi MERCI. Part I trials. Stroke. 2007; 38 (4): 1274-1280. (Pubitemid 351664267)
35. Gobin YP, Starkman S, Duckwiler GR, et al. MERCI 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke. 2004; 35 (12): 2848-2854.
36. Labiche LA, Al-Senani F, Wojner AW, et al. Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke. 2003; 34 (3): 695-698. (Pubitemid 36307395)
37. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, part I. Am J Neuroradiol. 2006; 27 (6): 1177-1182. (Pubitemid 44897621)
38. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke. 2005; 36 (7): 1432-1438. (Pubitemid 40967507)
39. Nogueira RG, Liebeskind DS, Sung G, et al. MERCI; Multi MERCI Writing Committee Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials. Stroke. 2009; 40: 3777-3783.
40. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002; 24; 59 (6): 862-867.
41. Mattie HP, Arnold M, Georgiadis D, et al. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign. Stroke. 2008; 39 (2), 379-383. (Pubitemid 351619459)
42. Rahme R, Abruzzo TA, Martin RH, et al. Is intra-arterial thrombolysis beneficial for M2 occlusions? Stroke. 2013; 44 (1): 240-242.
43. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study. Stroke. 2004; 35 (4): 904-911.
44. IMS II Trial Investigators.The Interventional Management of Stroke (IMS) II study. Stroke. 2007; 38 (7): 2127-2135.
45. Nogueira RG, Yoo AJ, Masrur S, et al. Safety of full-dose intravenous recombinant tissue plasminogen activator followed by multimodal endovascular therapy for acute ischemic stroke. J Neurointerv Surg. 2013; 5 (4): 298-301.
46. Smith WS, Sung G, Starkman S, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke 2005; 36 (7): 1432-1438. (Pubitemid 40967507)
47. Smith WS, Sung G, Saver J, et al. Mechanical thrombectomy for acute ischemic stroke: final results of the Multi MERCI trial. Stroke. 2008; 39 (4): 1205-1212. (Pubitemid 351440692)
48. Rymer MM, Budzik RF, Devlin TG, et al. Interventional acute stroke therapy with the merci retriever embolectomy device: Results from 1000 patients in a Open Label Prospective Multicenter Registry. International Stroke Conference. Los Angeles, CA: 2011. Late breaking science oral abstract 5. Abstract. Available at http://my.americanheart.org. Accessed Jan 25 2013.
49. Tarr R, Hsu D, Kulcsar Z, et al. The POST trial: initial post-market experience of the Penumbra system: revascularization of large vessel occlusion in acute ischemic stroke in the United States and Europe. J Neurointerv Surg. 2010; 2 (4): 341-344.
50. Burns TC, Rodriguez GJ, Patel S, et al. Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: a case-control study. Am J Neuroradiol. 2008; 29 (10): 1918-1924.
51. Toyota S, Sugiura S, Iwaisako K. Simultaneous combined intravenous recombinant tissue plasminogen activator and endovascular therapy for hyperacute middle cerebral artery Ml occlusion. Interv Neuroradiol. 2011; 17(1): 115-122.
52. Penumbra pivotal stroke trial investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke. 2009; 40 (8), 2761-2768.
53. Khatri P, Yeats SD, Mazighi M et al. Time to angiographic reperfusion is highly associated with good clinical outcome in the interventional management of Stroke Phase III (IMS III) trial. International Stroke Conference; Honolulu, Hawaii, 2013. Available at http://my.americanheart.org/ucm-448655.pdf. Accessed June 1 2013.
54. Jovin TG, Liebeskind DS, Gupta R, et al. Imaging-based endovascular therapy for acute ischemic stroke due to proximal intracranial anterior circulation occlusion treated beyond 8 hours from time last seen well retrospective multicenter analysis of 237 consecutive patients. Stroke. 2011; 42 (8): 2206-2211.
55. Albuquerque FC, Fiorella D, Hirsch JA, et al.The tribulations of stroke trials. J Neurointerv Surg. 2013; 5 (3): 181-183.
56. Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke. N Engl J Med. 2013; 368 (10): 904-913.
57. Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med. 2013; 368 (10): 914-923.
58. Demchuk AM, IMS III Investigators. IMS III: comparison of outcomes between IV and IV/IA treatment in baseline CTA confirmed ICA, M1, M2 and basilar occlusions. International Stroke Conference; Honolulu, Hawaii, 2013. Available at https://conference-cast.com. Accessed April 4 2013.
59. Lansberg MG, Straka M, Kemp S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012; 11 (10): 860-867.
60. Ribo M, Molina CA, Jankowitz B, et al. Stentrievers versus other endovascular treatment methods for acute stroke: comparison of procedural results and their relationship to outcomes. J Neurointerv Surg. 2013. [Epub ahead of print]
61. Koh JS, Lee SJ, Ryu CW, et al. Safety and efficacy of mechanical thrombectomy with solitaire stent retrieval for acute ischemic stroke: a systematic review. Neurointervention. 2012; 7 (1): 1-9.
62. Machi P, Costalat V, Lobotesis K, et al. Solitaire FR thrombectomy system: immediate results in 56 consecutive acute ischemic stroke patients. J Neurointerv Surg. 2012; 1; 4(1): 62-66.
63. Dávalos A, Pereira VM, Chapot R, et al. Solitaire Group. Retrospective multicenter study of solitaire FR for revascularization in the treatment of acute ischemic stroke. Stroke. 2012; 43 (10): 2699-2705.
64. Saver JL, Jahan R, Levy RI, et al. Solitaire flow restoration device versus the MERCI Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial. Lancet. 2012; 380 (9849): 1241-1249.
65. Dorn F, Stehle S, Lockau H, et al. Endovascular Treatment of Acute Intracerebral Artery Occlusions with the Solitaire Stent: Single-Centre Experience with 108 Recanalization Procedures. Cerebrovasc Dis 2012;34:70-77.
66. Broussalis E, Trinka E, Hitzl W, et al. Comparison of Stent-Retriever devices versus the MERCI Retriever for endovascular treatment of acute stroke. Am J Neuroradiol. 2013. 34 (2): 366-372.
67. San Román L, Obach V, Blasco J, et al. Single-center experience of cerebral artery thrombectomy using the Trevo device in 60 patients with acute ischemic stroke. Stroke. 2012; 43 (6): 1657-1659.
68. Pereira VM, Gralla J, Davalos A. Prospective, multicenter, single-arm study of mechanical thrombectomy using solitaire flow restoration in acute ischemic stroke. Stroke. 2013. [Epub ahead of print].
69. Mokin M, Dumont TM, Veznedaroglu E, et al. Solitaire FR thrombectomy for acute ischemic stroke: retrospective multicenter analysis of early postmarket experience after FDA approval. Neurosurgery. 2013. [Epub ahead of print].
70. Cohen JE, Rabinstein A A, Ramirez-de-Noriega F, et al. Excellent rates of recanalization and good functional outcome after stent-based thrombectomy for acute middle cerebral artery occlusion. Is it time for a paradigm shift? J Clin Neurosci. 2013; 20 (9): 1219-1223.
71. Tuilier T, Gallas S, Hosseini H, et al. Mechanical thrombectomy in acute embolic stroke: results of a single centre retrospective analysis of 36 patients treated with the Solitaire™ FR device. EJMINT. 2013; 1305000102.
72. Costalat V, Lobotesis K, Machi P, et al. Prognostic factors related to clinical outcome following thrombectomy in ischemic stroke (RECOST study). 50 patients prospective study. Eur J Radiol. 2012; 81 (12): 4075-4082.
73. Prothmann S, Lockau H, Dorn F, et al. The Phenox Clot Retriever as part of a multimodal mechanical thrombectomy approach in acute ischemic stroke: single center experience in 56 patients. ScientificWorld-Journal. 2012; 2012: 190763.
74. Roth C, Reith W, Walter S, et al. Mechanical recanalization with flow restoration in acute ischemic stroke: the ReFlow (mechanical recanalization with flow restoration in acute ischemic stroke) study. JACC Cardiovasc Interv. 2013; 6 (4): 386-391.
75. Bae GS, Kwon HJ, Kang CW, et al. Mechanical thrombectomy using a solitaire stent in acute ischemic stroke; initial experience in 40 patients. J Cerebrovasc Endovasc Neurosurg. 2012; 14 (3): 164-169.
76. Soize S, Barbe C, Kadziolka K, et al. Predictive factors of outcome and hemorrhage after acute ischemic stroke treated by mechanical thrombectomy with a stent-retriever. Neuroradiology. 2013; 55 (8): 977-987.
77. Raoult H, Eugène F, Ferré JC, et al. Prognostic factors for outcomes after mechanical thrombectomy with solitaire stent. J Neuroradiol. 2013. doi: 10.1016/j.neurad.2013.04.001. [Epub ahead of print]
78. Castaño C, Dorado L, Guerrero C, et al. Mechanical thrombectomy with the Solitaire AB device in large artery occlusions of the anterior circulation: a pilot study. Stroke. 2010; 41 (8): 1836-1840.
79. Miteff F, Faulder KC, Goh AC, et al. Mechanical thrombectomy with a self-expanding retrievable intracranial stent (Solitaire AB): experience in 26 patients with acute cerebral artery occlusion. Am J Neuroradiol. 2011; 32 (6): 1078-1081.
80. Rohde S, Haehnel S, Herweh C, et al. Mechanical thrombectomy in acute embolic stroke: preliminary results with the revive device. Stroke. 2011; 42 (10): 2954-2956.
81. Nogueira RG, Lutsep HL, Gupta R, et al,Trevo 2 Trialists. Trevo versus MERCI retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial. Lancet. 2012; 380 (9849): 1231-1240.
82. Vendrell JF, Mernes R, Nagot N, et al. Evaluation of an Intravenous-Endovascular Strategy in Patients with Acute Proximal Middle Cerebral Artery Occlusion. Am J Neuroradiol. 2013; 34 (3): 603-608.
83. Roubec, M, Kuliha, M, Procházka V, et al. A controlled trial of revascularization in acute stroke. Radiology. 2013; 266 (3): 871-878.
84. Rubiera M, Ribo M, Pagola J, et al. Bridging intravenous-intra-arterial rescue strategy increases recanalization and the likelihood of a good outcome in nonresponder intravenous tissue plasminogen activator-treated patients. A case-control study. Stroke. 2011; 42: 993-997.
85. Dembo T, Deguchi I, Fukuoka T, et al Additional endovascular therapy in patients with acute ischemic stroke who are nonresponsive to intravenous tissue plasminogen activator: usefulness of magnetic resonance angiography-diffusion mismatch. J Stroke Cerebrovasc Dis. 2012; [Epub ahead of print] doi:10.1016/j.jstrokecerebrovasdis.2012.07.002
86. Leker RR, Eichel R, Gomori JM, et al. Stent-based thrombectomy versus intravenous tissue plasminogen activator in patients with acute middle cerebral artery occlusion. Stroke. 2012; 43 (12): 3389-3391.
87. NINDS study group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA Stroke Study Group. Stroke. 1997; 28 (11): 2109-2118.
88. Larrue V, von Kummer RR, Muller A, et al. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke. 2001; 32 (2): 438-441. (Pubitemid 32155231)
89. Clark WM, Wissman S, Albers GW, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS study: a randomized controlled trial. Alteplase thrombolysis for acute noninterventional therapy in ischemic stroke. JAMA. 1999; 282 (21): 2019-2026.
90. Rouchaud A, Mazighi M, Labreuche J, et al. Outcomes of mechanical endovascular therapy for acute ischemic stroke: a clinical registry study and systematic review. Stroke. 2011; 42 (5): 1289-1294.
91. Mustanoja S, Meretoja A, Putaala J, et al. Outcome by stroke etiology in patients receiving thrombolytic treatment: descriptive subtype analysis. Stroke. 2011; 42 (1): 102-106.